Abstract
It is now widely recognized that perinatal exposure to maternal dysmetabolic conditions may influence cardiovascular diseases in offspring.1 Maternal hypercholesterolemia, in particular, increases the susceptibility to atherosclerosis in humans and experimental models. The translational relevance of developmental programming is obvious. If safe interventions in hypercholesterolemic mothers before or during pregnancy can attenuate pathogenic programming, atherogenesis may be reduced throughout adult life.1 Although the consequences of maternal hypercholesterolemia in humans are increasingly evident,2 the mechanisms involved remain largely unknown. See accompanying article on page 2053 In this edition of the journal, Trenteseaux et al3 identify a novel mechanism that may promote atherosclerosis in apoE−/− mice. In their study, homozygous female offspring of hypercholesterolemic (apoE−/−) mothers developed greater lesions in the aortic root than offspring of normocholesterolemic (apoE+/−) mothers, consistent with increased aortic atherosclerosis observed in LDL−/− mice or rabbits. Remarkably, maternal hypercholesterolemia was associated with higher plasma levels of trimethylamine-N-oxide …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Arteriosclerosis, Thrombosis, and Vascular Biology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.